Mechanism of flexibility control for ATP access of hepatitis C virus NS3 helicase

被引:4
作者
Palla, Mirko [1 ,2 ]
Chen, Chien-Pin [1 ]
Zhang, Yuan [1 ]
Li, Jingyuan [4 ]
Ju, Jingyue [2 ]
Liao, Jung-Chi [1 ,3 ]
机构
[1] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA
[2] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA
[3] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA
[4] Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China
基金
美国国家科学基金会;
关键词
molecular dynamics simulation; ATP-binding cleft; pairwise distance analysis; RMSF analysis; hinge motion; MOLECULAR-DYNAMICS; RNA HELICASE; PROTEIN FLEXIBILITY; MUTATIONAL ANALYSIS; PCRA HELICASE; MODEL; TRANSLOCATION; COORDINATION; RECOGNITION; TARGETS;
D O I
10.1080/07391102.2012.698236
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatitis C virus (HCV) NS3 helicase couples adenosine triphosphate (ATP) binding and hydrolysis to polynucleotide unwinding. Understanding the regulation mechanism of ATP binding will facilitate targeting of the ATP-binding site for potential therapeutic development for hepatitis C. T324, an amino acid residue connecting domains 1 and 2 of NS3 helicase, has been suggested as part of a flexible hinge for opening of the ATP-binding cleft, although the detailed mechanism remains largely unclear. We used computational simulation to examine the mutational effect of T324 on the dynamics of the ATP-binding site. A mutant model, T324A, of the NS3 helicase apo structure was created and energy was minimized. Molecular dynamics simulation was conducted for both wild type and the T324A mutant apo structures to compare their differences. For the mutant structure, histogram analysis of pairwise distances between residues in domains 1 and 2 (E291-Q460, K210-R464 and R467-T212) showed that separation between the two domains was reduced by 10% and the standard deviation by 33%. Root mean square fluctuation (RMSF) analysis demonstrated that residues in close proximity to residue 324 have at least 30% RMSF value reductions in the mutant structure. Solvent RMSF analysis showed that more water molecules were trapped near D290 and H293 in domain 1 to form an extensive interaction network constraining cleft opening. We also demonstrated that the T324A mutation established a new atomic interaction with V331, revealing that an atomic interaction cascade from T324 to residues in domains 1 and 2 controls the flexibility of the ATP-binding cleft.
引用
收藏
页码:129 / 141
页数:13
相关论文
共 40 条
  • [1] Large-scale conformational sampling of proteins using temperature-accelerated molecular dynamics
    Abrams, Cameron F.
    Vanden-Eijnden, Eric
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (11) : 4961 - 4966
  • [2] GROMACS - A MESSAGE-PASSING PARALLEL MOLECULAR-DYNAMICS IMPLEMENTATION
    BERENDSEN, HJC
    VANDERSPOEL, D
    VANDRUNEN, R
    [J]. COMPUTER PHYSICS COMMUNICATIONS, 1995, 91 (1-3) : 43 - 56
  • [3] Berendsen HJC, 1981, INTERMOLECULAR FORCE, V11, P331, DOI DOI 10.1111/J.1574-695X.1996.TB00128.X
  • [4] The role of dynamic conformational ensembles in biomolecular recognition
    Boehr, David D.
    Nussinov, Ruth
    Wright, Peter E.
    [J]. NATURE CHEMICAL BIOLOGY, 2009, 5 (11) : 789 - 796
  • [5] Carlson HA, 2000, MOL PHARMACOL, V57, P213
  • [6] Helicase structure and mechanism
    Caruthers, JM
    McKay, DB
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2002, 12 (01) : 123 - 133
  • [7] ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME
    CHOO, QL
    KUO, G
    WEINER, AJ
    OVERBY, LR
    BRADLEY, DW
    HOUGHTON, M
    [J]. SCIENCE, 1989, 244 (4902) : 359 - 362
  • [8] Challenges and successes in developing new therapies for hepatitis C
    De Francesco, R
    Migliaccio, G
    [J]. NATURE, 2005, 436 (7053) : 953 - 960
  • [9] Protein flexibility: its role in structure and mechanism revealed by molecular simulations
    Dodson, G
    Verma, CS
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (02) : 207 - 219
  • [10] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
    Druker, BJ
    Talpaz, M
    Resta, DJ
    Peng, B
    Buchdunger, E
    Ford, JM
    Lydon, NB
    Kantarjian, H
    Capdeville, R
    Ohno-Jones, S
    Sawyers, CL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1031 - 1037